Home Transcranial Direct Current Stimulation With Gamified Cognitive Control Training for Depression: A - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

At-Home Transcranial Direct Current Stimulation Combined With Gamified Cognitive Control Training for Depression: A Study

  • By

  • Esther Dechantsreiter

  • Frank Padberg

  • Yuval Benjamini

  • Stephan Goerigk

  • Linda Rubene-Kesele

  • Liene Konosonoka

  • Ulrike Vogelmann

  • Tamar Cohen

  • Naamah Lerner

  • Gerrit Burkhardt

  • Aldo Soldini

  • Fabienne Windel

  • Marios Fanourakis

  • Zeno Menestrina

  • Arthur Nguyen

  • Angela Pasqualotto

  • Takuya Morishita

  • Amir Dotan

  • Shira Ahissar

  • Alon Morash

  • Jonas Björklund

  • Lucia Bulubas

  • Daniel Keeser

  • Netta Assa

  • Rémy Gardier

  • Roser Viñals

  • Jean-Philippe Thiran

  • Ronen Segman

  • Omer Bonne

  • Amit Lotan

  • Friedhelm C. Hummel

  • Elmars Rancans

  • Daphne Bavelier

  • Mor Nahum

  • October 19, 2026

Share

Clinical Scorecard: At-Home Transcranial Direct Current Stimulation Combined With Gamified Cognitive Control Training for Depression: A Study

At a Glance

CategoryDetail
ConditionMajor depressive disorder (MDD)
Key MechanismsThe intervention combines tDCS targeting prefrontal activity with gamified cognitive control training (CCT) targeting cognitive processes linked to the dorsolateral prefrontal cortex; proposed complementary mechanisms include frontoparietal attentional control and reward circuitry.
Target PopulationAdults aged 18–65 years with primary MDD, a depressive episode lasting 4 weeks to 5 years, and a 17-item Hamilton Depression Rating Scale score of at least 13.
Care SettingMulticenter, sham-controlled randomized trial with remote home treatment after on-site onboarding at three university hospitals.

Key Highlights

  • DiSCoVeR was a 6-week, double-masked, sham-controlled randomized clinical trial conducted at three university hospitals.
  • The study assessed feasibility and safety as primary outcomes and compared depressive symptom change between double-active treatment and double-sham control as a secondary outcome.
  • Participants were randomized 1:1, with allocation stratified by site and MADRS symptom severity.
  • The intervention paired home-based tDCS with a gamified CCT video game; the supplied article excerpt does not report trial results.

Guideline-Based Recommendations

Diagnosis

  • Eligibility required MDD as the primary diagnosis established using DSM-5 criteria.
  • Participants required a 17-item Hamilton Depression Rating Scale score of 13 or higher.

Management

  • The study evaluated home-based tDCS combined with gamified CCT against a double-sham control; the excerpt does not provide efficacy findings or treatment recommendations.
  • Antidepressant medication was permitted if absent or maintained at a predefined dose for at least 4 weeks; psychotherapy was allowed if modality and frequency were documented.

Monitoring & Follow-up

  • The trial designated feasibility and safety as primary outcomes and depressive symptom change as a secondary outcome.
  • Participants received on-site onboarding before remote home administration.

Risks

  • Exclusions included acute suicidal risk, significant psychiatric comorbidity, significant neurologic disorder, gaming addiction, seizure history, unstable medical illness, pregnancy, and intracranial implants.
  • The excerpt describes the study's safety rationale but does not report adverse-event findings.

Patient & Prescribing Data

Adults aged 18–65 years with single-episode or recurrent MDD meeting the stated symptom-severity and episode-duration criteria; participants could be unmedicated or on a stable predefined antidepressant dose.

The intervention combined remotely administered home tDCS with gamified CCT after in-person onboarding. The excerpt does not specify stimulation parameters, session frequency, or clinical outcomes.

Clinical Best Practices

  • The trial obtained institutional review board approval and written informed consent from all participants.
  • Conduct followed Good Clinical Practice and the Declaration of Helsinki, and reporting followed CONSORT.
  • Randomization was centralized, concealed, and stratified by site and MADRS severity.

Related Resources & Content

    Original Source(s)

    Related Content